Coeptis says Nasdaq approves post-merger listing on Global Market as ZSQR

Reuters04-08
Coeptis says Nasdaq approves post-merger listing on Global Market as ZSQR
  • Coeptis received Nasdaq clearance for post-merger common stock listing on Nasdaq Global Market under ticker ZSQR, effective at merger close.
  • Listing change ties to planned merger with Z Squared, which would become wholly owned subsidiary; Coeptis would rename to Z Squared.
  • Transaction still awaits remaining customary closing conditions; closing expected in Q2 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coeptis Therapeutics Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604071205PRIMZONEFULLFEED9685420) on April 07, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment